Literature DB >> 19713034

p19(ras) Represses proliferation of non-small cell lung cancer possibly through interaction with Neuron-Specific Enolase (NSE).

Sang-Min Jang1, Jung-Woong Kim, Chul-Hong Kim, Daehwan Kim, Sangmyung Rhee, Kyung-Hee Choi.   

Abstract

p19(ras) is an alternative splicing product of the proto-oncogene c-H-ras pre-mRNA. In this study, we identified a novel p19(ras)-binding protein, Neuron-Specific Enolase (NSE), using the yeast two-hybrid method. NSE is one of the enolase families that convert 2-phospho-d-glycerate (PGA) to phosphoenolpyruvate (PEP) in the glycolysis pathway. In both endogenous and over-expressed systems, we confirmed interactions between p19(ras) and NSE via co-immunoprecipitation assay. We also identified the interaction region of p19(ras), which is required for binding with NSE. When full-length p19(ras) and C-terminal region are bound to NSE, it inhibits the enzymatic activity of NSE. Furthermore, p19(ras) interacted with Enolase alpha (Enoalpha) and repressed its enzymatic activity in vitro. p19(ras) repressed lung cancer cell proliferation mostly increased by NSE in H1299 cells. Taken together, these results suggest that p19(ras) is a novel regulator to suppress cell proliferation in lung cancer through the interaction with NSE. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713034     DOI: 10.1016/j.canlet.2009.08.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Prospective validation of quantitative NSE mRNA in pleural fluid of non-small cell lung cancer patients.

Authors:  Dongfang Tang; Mingzhao Wang; Aihua Sui; Yongjie Wang; Ronghua Yang; Zizong Wang; Yandong Zhao; Wenjie Jiao; Yi Shen
Journal:  Med Oncol       Date:  2013-09-01       Impact factor: 3.064

Review 2.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

3.  Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

Authors:  Y Wang; D Tang; A Sui; W Jiao; Y Luo; M Wang; R Yang; Z Wang; Y Shen
Journal:  Clin Transl Oncol       Date:  2012-10-11       Impact factor: 3.405

Review 4.  Gamma-enolase: a well-known tumour marker, with a less-known role in cancer.

Authors:  Tjasa Vizin; Janko Kos
Journal:  Radiol Oncol       Date:  2015-08-21       Impact factor: 2.991

5.  The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model.

Authors:  Roseli García-Cruz; Maria Camats; George A Calin; Chang-Gong Liu; Stefano Volinia; Cristian Taccioli; Carlo M Croce; Montse Bach-Elias
Journal:  BMC Med Genet       Date:  2015-07-03       Impact factor: 2.103

6.  Knockdown of neuron-specific enolase suppresses the proliferation and migration of NCI-H209 cells.

Authors:  Xia Liu; Shousheng Liu; Juan Fu; Jinsheng Huang; Chengyin Weng; Xisheng Fang; Mingmei Guan; Yong Wu; Lin Yang; Guolong Liu
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

7.  Prognostic Value of Enolase Gene Family in Colon Cancer.

Authors:  Xiaohang Pan; Huawen Wu; Guofu Chen; Wenhuan Li
Journal:  Med Sci Monit       Date:  2020-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.